Skip to content
TrackPodcasts
businessJul 9, 20264:36pending

Deutz Buy, Astrazeneca's Trial, Computacenter Up

Stock Movers

About this episode

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Deutz agreed to buy military vehicle maker Flensburger Fahrzeugbau Gesellschaft mbH for €1.6 billion ($1.8 billion), expanding further into the defense sector to benefit from Europe’s rearmament drive.
- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.
- Computacenter expects first-half adjusted profit before tax to be double the prior year’s first-half figure of £81.5m, following 2Q performance ahead of expectations.

See omnystudio.com/listener for privacy information.

Get every episode summarized

Each time Stock Movers publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Deutz Buy, Astrazeneca's Trial, Computacenter Up

Stock Movers

0:00
4:36

More episodes

More from Stock Movers

View all episodes →